Glean

The investment case for Glean's pre-IPO CFD rests on three pillars: a distinctive access structure that bypasses traditional accreditation barriers, an ARR trajectory that reflects accelerating enterprise AI adoption, and a valuation history that has re-rated sharply upward across successive funding rounds.

Against these, a set of pre-IPO-specific risks must be weighed clearly before any position is opened.

The Access Wedge

Conventional routes to private-market exposure, platforms such as EquityZen, Forge Global, and Hiive, typically require accredited investor status and carry meaningful capital minimums, placing pre-IPO names like Glean out of reach for most retail participants.

CoinUnited's pre-IPO CFD provides synthetic price exposure to Glean's private-market reference price from a minimum of US$100, with no accreditation requirement and no traditional bank account needed.

This is not equity. The CFD confers no shareholding, no voting rights, no dividend entitlement, and no allocation in any eventual IPO. It is a derivative that tracks the private-market reference price, a distinction that carries both structural limitations and genuine utility for traders seeking directional price exposure.

The Growth Story

Glean's ARR progression is the most quantifiable signal available for a company with no public financials. TechCrunch reported that Glean crossed $300 million in ARR in May 2026. The intervals matter: nine months elapsed between the $100 million and $200 million milestones; only six months separated $200 million from $300 million.

That compression in growth cycles is consistent with a category, enterprise AI search, where procurement decisions are accelerating and budget displacement from legacy tools is ongoing.

Valuation Trajectory

Glean's private valuation has risen substantially across its most recent funding rounds. Reuters and TechCrunch both reported a $7.2 billion post-money valuation at the Series F round in June 2025. That compares with a $4.6 billion valuation at Series E in September 2024, per Reuters, a re-rating of roughly 57% over approximately nine months.

Backing comes from a roster of marquee venture and crossover investors including Sequoia Capital, Kleiner Perkins, General Catalyst, Lightspeed Venture Partners, Altimeter Capital, Wellington Management, Coatue, and IVP. The presence of crossover investors, funds that also hold public equities, is often read as a signal of IPO readiness, though it is not a guarantee of timing.

Pre-IPO Risk Factors

Several risks are specific to this instrument and asset class:

Traders evaluating a position should treat these risks as structural, not incidental. The enterprise AI category has attracted significant capital, but private-stage companies carry a fundamentally different risk profile from publicly listed peers. Price discovery is thinner, exit optionality is limited to closing the CFD position, and no public disclosure regime applies to Glean's operations.

For context on how Glean fits within the broader landscape of private-stage companies approaching public markets, the 2026 Pre-IPO Market Outlook provides relevant sector-level perspective.

CoinUnited's GLEAN instrument is a CFD-style derivative that provides synthetic price exposure to Glean's private-market reference price. It is not equity. Opening a position creates no shareholding, voting rights, dividend entitlement, or IPO allocation in Glean.

Instrument Mechanics

The GLEAN pre-IPO CFD tracks Glean's private-market reference price synthetically. Because no public exchange lists Glean shares, the reference price is derived from private-market data rather than a central order book. Traders should be aware of two structural differences from standard equity CFDs:

• -Spreads: Pre-IPO instruments can carry wider bid-ask spreads than publicly listed equities, reflecting thinner underlying liquidity in the private market.
• -Reference price updates: The synthetic price may update less frequently than a live exchange feed. Position entry and exit costs should be modeled with this in mind.

Neither of these characteristics prevents the instrument from functioning as a vehicle for directional exposure, but they inform how aggressively a position should be sized.

Leverage Parameters

CoinUnited offers up to 100x leverage on the GLEAN pre-IPO CFD. At 100x, a 1% move in the reference price produces a 100% gain or loss on the margin deployed. The mechanics are straightforward:

For a hypothetical worked example: a trader deposits US$500 as margin and opens a US$50,000 notional long position at 100x. A 2% rise in the reference price returns US$1,000 on the deployed margin. A 1% adverse move fully erodes that same margin.

Pre-IPO instruments, by nature, can exhibit larger reference-price revisions than public equities, particularly around funding announcements or ARR disclosures, so leverage selection should reflect that elevated volatility profile.

Access Conditions

The GLEAN CFD is retail-accessible: no accreditation is required, and the minimum exposure starts from US$100. Accounts are funded and withdrawn in crypto, which removes the need for a traditional bank account and avoids the documentation burden of conventional brokerages.

Key Catalysts to Monitor

For a synthetic instrument tracking a private company, the catalyst set differs from a public equity. Traders should monitor:

• -ARR milestones and growth-rate data: Glean crossed $300 million in ARR as of May 2026, compressing from $200 million in six months. Further ARR announcements are the primary public signal of business momentum and have historically moved private-market valuations for comparable enterprise AI companies.
• -S-1 filing activity: No public S-1 has been filed and no IPO timetable has been announced. Any confidential or public S-1 filing would be a material event for the reference price.
• -New funding rounds or secondary tender events: Successive rounds, from the $4.6 billion Series E in September 2024 to the $7.2 billion Series F in June 2025, have each re-rated the private valuation sharply. A new primary round or secondary tender would update the reference price anchor.
• -Enterprise partnership announcements: Major enterprise agreements signal commercial traction and can shift private-market sentiment.

IPO Event Handling

Traders holding the GLEAN pre-IPO CFD at the time of any public listing should understand a critical point: the synthetic position does not automatically convert to listed equity. CoinUnited's terms will govern how the instrument is settled, converted, or closed in such an event, and traders should review those terms directly before an IPO announcement materializes.

Around any IPO announcement, the practical risks include reference-price uncertainty during the transition from private to public valuation, potential spread widening as the instrument approaches settlement, and changes in liquidity conditions. These dynamics are distinct from those of a standard post-IPO equity CFD, where a live exchange price is continuously available.

Position management, including reducing size ahead of a potential listing, is a risk-management consideration specific to this instrument type.